Adam Crystal
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
Adam S.
Crystal is currently Principal at The General Hospital Corp.
since 2013 and President-Research & Development at Tango Therapeutics, Inc. since 2023.
Formerly, Dr. Crystal was Senior Director at Novartis Institutes for Biomedical Research, Inc. from 2014 to 2019 and Chief Medical Officer at C4 Therapeutics, Inc. from 2019 to 2023.
Education includes a doctorate from the University of Pennsylvania Medical Center and an undergraduate degree from the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 115’743 ( 0.08% ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.02.2023 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | 01.01.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
| C4 THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.02.2023 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Direktor/Vorstandsmitglied | 01.02.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen